Brazil vs Nicaragua: The number of people with susceptibility test result for rifampicin
Brazil
50.47
in 2021
Nicaragua
46.72
in 2021
Brazil rank
114th
Nicaragua rank
117th
The number of people with susceptibility test result for rifampicin over time
- Brazil
- Nicaragua
How they compare
Brazil currently reports 50.47 against 46.72 in Nicaragua, a difference of 3.75.
That makes Brazil's figure about 1.1 times Nicaragua's.
The two have swapped places 4 times across 5 shared years of data; in 2017 it was Brazil ahead.
Brazil ranks 114th and Nicaragua ranks 117th of 146 countries.
Nicaragua has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.74 | 44.17 | 2.43 | Nicaragua |
| 2020s | 51.96 | 71.24 | 19.28 | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brazil or Nicaragua?
- Brazil, at 50.47 against 46.72 in Nicaragua as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brazil and Nicaragua?
- 3.75, with Brazil ahead.
- How many years of comparable data are there for Brazil and Nicaragua?
- 5 years are reported by both, from 2017 to 2021.
- How do Brazil and Nicaragua rank globally for the number of people with susceptibility test result for rifampicin?
- Brazil ranks 114th and Nicaragua ranks 117th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.